MRK Jun 2024 133.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:59PM EDT. Market open.
Loading interactive chart…
- Business Wire
CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
RAHWAY, N.J., June 28, 2024--CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
- Investor's Business Daily
Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection
Merck stock tumbled under its 50-day moving average Thursday after the FDA rejected its Daiichi Sankyo-partnered cancer drug.
- Simply Wall St.
Merck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?
Merck's (NYSE:MRK) stock is up by 2.7% over the past week. Given that the markets usually pay for the long-term...
© 2024 Yahoo. All rights reserved.